Group Dynamics- Taichu Group

News Information

The latest information of Taichu Group is all here

Home > News > Group Dynamics

VivaVision Biotech and AceMab Announce Strategic Collaboration to Develop Antibody Therapeutics for Retinal Diseases

On May 18, 2022, in Shanghai, China, VivaVision Biotech (Shanghai) Co., Ltd. (referred to as "VivaVision Biotech") and Shanghai AceMab Co., Ltd. (referred to as "AceMab") announced a strategic partnership to jointly develop bispecific antibody therapeutics for retinal diseases.

05-27

2022

< 1 2 3 >

Tel021-80403636

E-mailmarketing@taichubio.com

AddressNo. 308 Pingda Road, Lingang Special Area,Shanghai, China

AceMab Wechat official account

Taichu Biotechnology Wechat official account

Tarlead Wechat official account

TJR BIO Wechat official account

Taichu (Shenzhen) Wechat official account

Copyright ©2023 Taichu Group. All Rights Reserved沪ICP备2023012905号-1

Legal Notice丨 Website Map丨

Links

Baidu